Literature DB >> 15146038

Overview of the diagnosis and management of brain, spine, and meningeal metastases.

G E Gerrard1, K N Franks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15146038      PMCID： PMC1765655          DOI： 10.1136/jnnp.2004.040493

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

2.  Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

Authors:  C J Vecht; A Hovestadt; H B Verbiest; J J van Vliet; W L van Putten
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

3.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

4.  Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

Authors:  C J Vecht; H Haaxma-Reiche; E M Noordijk; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

5.  Prophylactic anticonvulsants in patients with brain tumour.

Authors:  Peter A Forsyth; Susan Weaver; Dorcas Fulton; Penelope M A Brasher; Garnette Sutherland; Doug Stewart; Neil A Hagen; Penny Barnes; J Greg Cairncross; Lisa M DeAngelis
Journal:  Can J Neurol Sci       Date:  2003-05       Impact factor: 2.104

6.  A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

Authors:  A H Mintz; J Kestle; M P Rathbone; L Gaspar; H Hugenholtz; B Fisher; G Duncan; P Skingley; G Foster; M Levine
Journal:  Cancer       Date:  1996-10-01       Impact factor: 6.860

7.  Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression.

Authors:  P Levack; J Graham; D Collie; R Grant; J Kidd; I Kunkler; A Gibson; D Hurman; N McMillan; R Rampling; L Slider; P Statham; D Summers
Journal:  Clin Oncol (R Coll Radiol)       Date:  2002-12       Impact factor: 4.126

8.  Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial.

Authors:  S Sørensen; S Helweg-Larsen; H Mouridsen; H H Hansen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860
  9 in total
  6 in total

Review 1.  [Infratentorial tumors].

Authors:  I Q Grunwald; C Veith; M Backens; C Roth; P Papanagiotou; W Reith
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

2.  Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells.

Authors:  M Lorger; H Lee; J S Forsyth; B Felding-Habermann
Journal:  J Neurooncol       Date:  2011-02-27       Impact factor: 4.130

3.  Gemcitabine plus oxaliplatin for the treatment of leptomeningeal metastases of non-small cell lung cancer: A case report and review of the literature.

Authors:  Chong Bai; Hui Shi; Dan Liu; Tianyi Zhu; Zhenli Hu; Qiang Li
Journal:  Oncol Lett       Date:  2013-03-19       Impact factor: 2.967

4.  Tumor microenvironment in the brain.

Authors:  Mihaela Lorger
Journal:  Cancers (Basel)       Date:  2012-02-22       Impact factor: 6.639

5.  Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell-Specific Gene Promoters.

Authors:  Tereza Andreou; Nora Rippaus; Krzysztof Wronski; Jennifer Williams; David Taggart; Stephanie Cherqui; Ashley Sunderland; Yolanda D Kartika; Teklu Egnuni; Rebecca J Brownlie; Ryan K Mathew; Sheri L Holmen; Christopher Fife; Alastair Droop; Mihaela Lorger
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

Review 6.  Immune Checkpoint Blockade - How Does It Work in Brain Metastases?

Authors:  Mihaela Lorger; Tereza Andreou; Christopher Fife; Fiona James
Journal:  Front Mol Neurosci       Date:  2019-11-21       Impact factor: 5.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.